SUNPHARMANSESun Pharmaceutical Industries Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 8 Oct, 2025 · 20:23 IST

Tribunal approves merger of five wholly owned Sun Pharma subsidiaries

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.4%Reaction day
₹1631.10
prior close
₹1645.00
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.5%+0.9% vs market
Pharmaceuticals peers, median of 153sector+0.5%+1.0% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty 100 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.5
15m
+0.5
30m
+0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.4+0.5+0.9+0.5+1.0
Next day
+2.4+0.9+1.5+0.6+1.8
2d
+2.2+0.7+1.5+0.3+1.9
3d
+1.3+0.3+0.9-0.7+2.0
4d
+1.3+1.2+0.2-0.7+2.0
5d
+1.6+2.1-0.6-0.2+1.8
1w
+3.5+3.0+0.5+0.2+3.3
15d
+3.7+2.7+1.0-0.2+3.8
1m
+3.8+2.1+1.7-2.3+6.1
2m
+8.8+2.5+6.2-5.4+14.2
3m
+6.5+2.2+4.3-6.3+12.8
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

India's National Company Law Tribunal approved Sun Pharma's plan to merge five wholly owned units into the parent company, effective 1 April 2023: Sun Pharmaceutical Medicare, Green Eco Development Centre, Faststone Mercantile, Realstone Multitrade and Skisen Labs. It also shifts the General Reserve to Retained Earnings. Sun Pharmaceutical Medicare posted FY2024 income of Rs 3.42 billion and operating profit of Rs 118.4 million.

Likely market impact

Likely limited immediate effect on share count or earnings. The consolidation may simplify group structure and reporting.